• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症治疗后的心脏毒性

Cardiotoxicity Following Cancer Treatment.

作者信息

Walls G M, Lyon A R, Harbinson M T, Hanna G G

机构信息

The Royal Marsden Hospital NHS Foundation Trust, Fulham Road, London.

National Heart and Lung Institute, Imperial College London; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London.

出版信息

Ulster Med J. 2017 Jan;86(1):3-9.

PMID:28298705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5324172/
Abstract

More than half of those born after 1960 will develop cancer during their lifetime. Fortunately, owing to improved diagnosis and treatment, cure rates have risen steadily over the last three decades. With an increased survivorship, more will experience adverse effects of cancer therapeutics on the heart. As the oncologist's focus begins to encompass the issues of cancer survivorship, awareness of the management of cardiac toxicity would be prudent for all physicians looking after patients with cancer.

摘要

1960年以后出生的人,超过半数在一生中会患上癌症。幸运的是,由于诊断和治疗水平的提高,在过去三十年中治愈率稳步上升。随着生存率的提高,更多的人将经历癌症治疗对心脏产生的不良反应。由于肿瘤学家的关注点开始涵盖癌症幸存者的问题,对于所有照料癌症患者的医生而言,了解心脏毒性的管理方法是明智之举。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0b1/5324172/7b45ac38a5ae/umj0086-0003-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0b1/5324172/58665e286d5d/umj0086-0003-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0b1/5324172/7b45ac38a5ae/umj0086-0003-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0b1/5324172/58665e286d5d/umj0086-0003-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0b1/5324172/7b45ac38a5ae/umj0086-0003-f2.jpg

相似文献

1
Cardiotoxicity Following Cancer Treatment.癌症治疗后的心脏毒性
Ulster Med J. 2017 Jan;86(1):3-9.
2
Cardiac toxicity in breast cancer survivors: review of potential cardiac problems.乳腺癌幸存者的心脏毒性:潜在心脏问题综述
Clin Cancer Res. 2008 Jan 1;14(1):14-24. doi: 10.1158/1078-0432.CCR-07-1033.
3
Cardiac complications in cancer treatment - A review.癌症治疗中心血管并发症——综述。
Hellenic J Cardiol. 2017 May-Jun;58(3):190-193. doi: 10.1016/j.hjc.2016.12.003. Epub 2016 Dec 20.
4
[Cardiologic follow up of an oncologic patient].[一位肿瘤患者的心脏科随访]
Rev Med Suisse. 2010 Jun 2;6(251):1133-4, 1136-9.
5
Cardiotoxicity from the cardiologist's perspective.心脏病专家视角下的心脏毒性
Future Cardiol. 2015 Jul;11(4):425-32. doi: 10.2217/fca.15.47. Epub 2015 Aug 3.
6
Cardiotoxicity of Contemporary Breast Cancer Treatments.当代乳腺癌治疗的心脏毒性。
Curr Treat Options Oncol. 2019 May 9;20(6):51. doi: 10.1007/s11864-019-0646-1.
7
Conference on long-term normal tissue effects of cancer treatment: summary of cardiac portion of cardiopulmonary workshop.癌症治疗长期正常组织效应会议:心肺研讨会心脏部分总结
Cancer Clin Trials. 1981;4 Suppl:53-9.
8
[Cardiotoxicity as undesired side effect in the treatment of breast cancer].[心脏毒性作为乳腺癌治疗中不良副作用]
Postepy Hig Med Dosw (Online). 2014 May 8;68:483-97. doi: 10.5604/17322693.1101581.
9
Common Cardiovascular Complications of Cancer Therapy: Epidemiology, Risk Prediction, and Prevention.癌症治疗的常见心血管并发症:流行病学、风险预测和预防。
Annu Rev Med. 2018 Jan 29;69:97-111. doi: 10.1146/annurev-med-041316-090622.
10
[Cardiovascular complications of cancers and anti-cancer therapy].[癌症及抗癌治疗的心血管并发症]
Vnitr Lek. 2017 Spring;63(3):200-209.

引用本文的文献

1
Risk of cardiovascular disease among cancer survivors: systematic review and meta-analysis.癌症幸存者患心血管疾病的风险:系统评价与荟萃分析。
EClinicalMedicine. 2025 Jun 5;84:103274. doi: 10.1016/j.eclinm.2025.103274. eCollection 2025 Jun.
2
Chemotherapy periodization to maximize resistance training adaptations in oncology.化疗分期以最大限度地提高肿瘤患者的抗阻训练适应性。
Cancer Chemother Pharmacol. 2023 Nov;92(5):357-367. doi: 10.1007/s00280-023-04576-x. Epub 2023 Aug 15.
3
Validation of an established deep learning auto-segmentation tool for cardiac substructures in 4D radiotherapy planning scans.

本文引用的文献

1
Breast Cancer Therapy-Related Cardiac Dysfunction in Adult Women Treated in Routine Clinical Practice: A Population-Based Cohort Study.在常规临床实践中治疗的成年女性乳腺癌治疗相关心脏功能障碍:一项基于人群的队列研究。
J Clin Oncol. 2016 Jul 1;34(19):2239-46. doi: 10.1200/JCO.2015.65.1505. Epub 2016 Apr 18.
2
Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol.辅助性乳腺癌治疗期间心脏功能障碍的预防(PRADA):一项关于坎地沙坦和美托洛尔的2×2析因、随机、安慰剂对照、双盲临床试验。
Eur Heart J. 2016 Jun 1;37(21):1671-80. doi: 10.1093/eurheartj/ehw022. Epub 2016 Feb 21.
3
用于4D放射治疗计划扫描中心脏亚结构的一种成熟深度学习自动分割工具的验证。
Phys Imaging Radiat Oncol. 2022 Jul 26;23:118-126. doi: 10.1016/j.phro.2022.07.003. eCollection 2022 Jul.
4
Increased standardised incidence ratio of cardiovascular diseases among colorectal cancer patients.结直肠癌患者心血管疾病的标准化发病比增加。
Int J Colorectal Dis. 2022 Apr;37(4):887-894. doi: 10.1007/s00384-022-04129-3. Epub 2022 Mar 17.
5
Clinical implications of chemotherapeutic agent organ toxicity on perioperative care.化疗药物器官毒性对围手术期护理的临床意义。
Biomed Pharmacother. 2022 Feb;146:112503. doi: 10.1016/j.biopha.2021.112503. Epub 2021 Dec 15.
6
Florida Inter-Specialty Collaborative Project to Improve Cardio-Oncology Awareness and Identify Existing Knowledge Gaps.佛罗里达跨专业合作项目,旨在提高心脏肿瘤学认知并识别现有知识差距。
JACC CardioOncol. 2020 Sep 15;2(3):535-538. doi: 10.1016/j.jaccao.2020.06.009. eCollection 2020 Sep.
7
[Docetaxel or abiraterone in combination with androgen deprivation therapy for metastatic prostate cancer].多西他赛或阿比特龙联合雄激素剥夺疗法治疗转移性前列腺癌
Urologe A. 2019 Oct;58(10):1185-1197. doi: 10.1007/s00120-019-0953-y.
8
Cardiotoxicity of Anticancer Therapeutics.抗癌治疗的心脏毒性
Front Cardiovasc Med. 2018 Feb 7;5:9. doi: 10.3389/fcvm.2018.00009. eCollection 2018.
9
Synergistic apoptotic effects of apigenin TPGS liposomes and tyroservatide: implications for effective treatment of lung cancer.芹菜素TPGS脂质体与酪丝缬肽的协同凋亡作用:对肺癌有效治疗的意义
Int J Nanomedicine. 2017 Jul 17;12:5109-5118. doi: 10.2147/IJN.S140096. eCollection 2017.
Cardiac Side-effects From Breast Cancer Radiotherapy.
乳腺癌放疗的心脏副作用
Clin Oncol (R Coll Radiol). 2015 Nov;27(11):621-9. doi: 10.1016/j.clon.2015.06.007. Epub 2015 Jun 28.
4
Radiotherapy in patients with pacemakers and implantable cardioverter defibrillators: a literature review.起搏器和植入式心脏复律除颤器患者的放射治疗:文献综述。
Europace. 2016 Apr;18(4):479-91. doi: 10.1093/europace/euv135. Epub 2015 Jun 3.
5
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.立体定向消融放疗与肺叶切除术治疗可手术的Ⅰ期非小细胞肺癌:两项随机试验的汇总分析
Lancet Oncol. 2015 Jun;16(6):630-7. doi: 10.1016/S1470-2045(15)70168-3. Epub 2015 May 13.
6
Risk of valvular heart disease after treatment for Hodgkin lymphoma.霍奇金淋巴瘤治疗后发生心脏瓣膜病的风险。
J Natl Cancer Inst. 2015 Feb 23;107(4). doi: 10.1093/jnci/djv008. Print 2015 Apr.
7
Cardiac risk in the treatment of breast cancer: assessment and management.乳腺癌治疗中心血管风险:评估与管理。
Breast Cancer (Dove Med Press). 2015 Jan 16;7:21-35. doi: 10.2147/BCTT.S47227. eCollection 2015.
8
Is cardiac toxicity a relevant issue in the radiation treatment of esophageal cancer?心脏毒性在食管癌放射治疗中是一个相关问题吗?
Radiother Oncol. 2015 Jan;114(1):85-90. doi: 10.1016/j.radonc.2014.11.037. Epub 2014 Dec 30.
9
Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.癌症治疗期间及之后成年患者多模态成像评估专家共识:美国超声心动图学会和欧洲心血管影像协会的报告
Eur Heart J Cardiovasc Imaging. 2014 Oct;15(10):1063-93. doi: 10.1093/ehjci/jeu192.
10
Cardiotoxicity of concomitant radiotherapy and trastuzumab for early breast cancer.早期乳腺癌同步放化疗和曲妥珠单抗的心脏毒性。
Radiol Oncol. 2014 Apr 25;48(2):105-12. doi: 10.2478/raon-2013-0040. eCollection 2014 Jun.